Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial.
Sabbatini PJ, Kudryashov V, Ragupathi G, Danishefsky SJ, Livingston PO, Bornmann W, Spassova M, Zatorski A, Spriggs D, Aghajanian C, Soignet S, Peyton M, O'Flaherty C, Curtin J, Lloyd KO.
Sabbatini PJ, et al.
Int J Cancer. 2000 Jul 1;87(1):79-85.
Int J Cancer. 2000.
PMID: 10861456
Clinical Trial.